Pliant Therapeutics PLRX
NASDAQ PLRX
$1.03 -0.01 (-1.43%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pliant Therapeutics (PLRX) Price to Earnings (2020)

Updated

Pliant Therapeutics' Price to Earnings was 123.83 in Q3 2020, up 161.2% from the prior quarter.

Analysis

Pliant Therapeutics (PLRX) Price to Earnings (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Pliant Therapeutics 65.02 Mn 65.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 123.83
Jun 30, 2020 47.40
API Access

Pliant Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=PLRX&period=max&api_key=YOUR_API_KEY